Role of Farletuzumab in Epithelial Ovarian Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|25|3812-3815

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.25, 2012-07, pp. : 3812-3815

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3775-3783

Bentham Science Publishers

Access to resources Recommend Favorite

The Expression of Interleukin-10 in Patients with Primary Ovarian Epithelial Carcinoma and in Ovarian Carcinoma Cell Lines

By Zhou J   Ye F   Chen H   Lv W   Gan N  

The Journal of International Medical Research, Vol. 35, Iss. 3, 2007-05 ,pp. : 290-300

Field House Publishing

Access to resources Recommend Favorite

Role of nerve growth factor and FSH receptor in epithelial ovarian cancer

By Bose Chinmoy K  

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 194-197

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Epithelial-Mesenchymal Transition in Ovarian Cancer Progression: A Crucial Role for the Endothelin Axis

By  

Cells Tissues Organs, Vol. 185, Iss. 1-3, 2007-06 ,pp. : 85-94

Karger

Access to resources Recommend Favorite

Relations between GPR4 Expression, Microvascular Density (MVD) and Clinical Pathological Characteristics of Patients with Epithelial Ovarian Carcinoma (EOC)

By  

Current Pharmaceutical Design, Vol. 20, Iss. 11, 2014-04 ,pp. : 1904-1916

Bentham Science Publishers

Access to resources Recommend Favorite